Subscribe to our channel! rupt.ly/subscribe
Health Director of Milan Galeazzi Orthopaedic Institute Fabrizio Ernesto Pregliasco spoke about recently announced reductions in the delivery of the Pfizer-BioNTech coronavirus vaccine to Italy in Milan on Thursday.
“There are problems, but they are related to a campaign that has organisational difficulties, which must be carried out quickly,” Pregliasco explained.
“We do not know the agreements in the contract, the indications and reciprocal promises on deliveries. In media terms, a defined and unilateral communication, with an unconventional distribution, leaves a bad taste in the mouth regarding the effectiveness and progress of the vaccination campaign,” he commented about Pfizer’s roll-out difficulties.
Pregliasco remarks come after Pfizer told Italy it would reduce vaccine deliveries to the country by 29 percent, as the company implement changes to its manufacturing processes in order to boost production, with the Italian government announcing its intention to sue Pfizer over the delays on Wednesday.
“We have no alternative, we are with bated breath to be able to better manage the management of the second dose of the vaccine in the right timing,” he continued, while urging people to be patient.
“We must not exceed in the understandable desire to get vaccinated and we must find together, structures and institutions, the ways to solve these problems that seem physiological to me,” Pregliasco said.
Italy has been one of the hardest-hit countries by the coronavirus, recording 2,428,221 confirmed COVID-19 cases and 84,202 related deaths since the start of the pandemic according to data compiled by Johns Hopkins University.
#Italy #Milan #COVID19 #Vaccines
Video ID: 20210122-004
Video on Demand: https://ruptly.tv/videos/20210122-004
Contact: [email protected]